HEPATITIS-C VIRUS ACUTE EXACERBATION DURING CHEMOTHERAPY AND RADIOTHERAPY FOR ESOPHAGEAL-CARCINOMA

被引:18
作者
DEPREE, C
GIOSTRA, E
GALETTO, A
PERRIN, L
ZULIAN, GB
机构
[1] UNIV HOSP GENEVA,DEPT MED,DIV ONCOHEMATOL,CH-1211 GENEVA 14,SWITZERLAND
[2] UNIV HOSP GENEVA,DEPT MED,DIV GASTROENTEROL,GENEVA,SWITZERLAND
[3] UNIV HOSP GENEVA,CENT VIROL LAB,GENEVA,SWITZERLAND
关键词
CHEMOTHERAPY; HEPATITIS; HEPATITIS C VIRUS;
D O I
10.1093/oxfordjournals.annonc.a059022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: We report the first case of an hepatitis C virus positive patient presenting with a solid tumor and developing an exacerbation of his hepatitis C after chemotherapy. Case report: A 56-year-old white male, previously infected with hepatitis C virus and treated for epidermoid carcinoma of the oesophagus, developed hepatitis (alamine aminotransferase 2376 U/l and aspartate aminotransferase 2262 U/l) after chemotherapy with cisplatin and vinblastine. Methods: Polymerase chain reaction detected hepatitis C virus RNA in the serum during the acute phase, which returned to negative 14 weeks later. Discussion: Viral replication was probably increased during immunosuppression induced by chemotherapy. Enhanced cellular immune response in the recovery phase was the most likely cause of the hepatitis. Conclusions: More attention should be paid to liver function tests in patients with a previous history of hepatitis C virus infection. Polymerase chain reaction identification of hepatitis C virus RNA can be a very useful tool that permits rapid diagnosis and appropriate management of such cases.
引用
收藏
页码:861 / 862
页数:2
相关论文
共 11 条
[1]  
FAN FS, 1991, BONE MARROW TRANSPL, V8, P417
[2]   REACTIVATION OF CHRONIC HEPATITIS-C AFTER WITHDRAWAL OF IMMUNOSUPPRESSIVE THERAPY [J].
GRUBER, A ;
LUNDBERG, LG ;
BJORKHOLM, M .
JOURNAL OF INTERNAL MEDICINE, 1993, 234 (02) :223-225
[3]   REACTIVATION OF CHRONIC HEPATITIS B-VIRUS INFECTION BY CANCER-CHEMOTHERAPY [J].
HOOFNAGLE, JH ;
DUSHEIKO, GM ;
SCHAFER, DF ;
JONES, EA ;
MICETICH, KC ;
YOUNG, RC ;
COSTA, J .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (04) :447-449
[4]   TREATMENT OF CHRONIC NON-A,NON-B HEPATITIS WITH RECOMBINANT HUMAN ALPHA-INTERFERON - A PRELIMINARY-REPORT [J].
HOOFNAGLE, JH ;
MULLEN, KD ;
JONES, DB ;
RUSTGI, V ;
DIBISCEGLIE, A ;
PETERS, M ;
WAGGONER, JG ;
PARK, Y ;
JONES, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) :1575-1578
[5]   FULMINANT HEPATITIS-C VIRAL-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
KANAMORI, H ;
FUKAWA, H ;
MARUTA, A ;
HARANO, H ;
KODAMA, F ;
MATSUZAKI, M ;
MIYASHITA, H ;
MOTOMURA, S ;
OKUBO, T ;
YOSHIBA, M ;
SEKIYAMA, K .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (02) :109-111
[6]   INTERFERON THERAPY FOR CHRONIC NON-A NON-B AND CHRONIC DELTA LIVER-DISEASE IN HEMOPHILIA [J].
LEE, CA ;
KERNOFF, PBA ;
KARAYIANNIS, P ;
THOMAS, HC .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) :235-238
[7]  
PECHEREBERTSCHI A, 1992, CLIN EXP IMMUNOL, V89, P419
[8]   CISPLATIN-INDUCED HEPATIC TOXICITY [J].
POLLERA, CF ;
AMEGLIO, F ;
NARDI, M ;
VITELLI, G ;
MAROLLA, P .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) :318-319
[9]   FULMINANT HEPATIC-FAILURE IN NON-HODGKIN LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY [J].
SOH, LT ;
ANG, PT ;
SNG, I ;
CHUA, EJ ;
ONG, YW .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1338-1339
[10]  
SUBAR M, 1986, CANCER TREAT REP, V70, P690